Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides
The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of va...
Gespeichert in:
Veröffentlicht in: | Journal of neuroendocrinology 2003-06, Vol.15 (6), p.564-571 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 571 |
---|---|
container_issue | 6 |
container_start_page | 564 |
container_title | Journal of neuroendocrinology |
container_volume | 15 |
creator | Jørgensen, H. Kjær, A. Knigge, U. Møller, M. Warberg, J. |
description | The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion. |
doi_str_mv | 10.1046/j.1365-2826.2003.01032.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73223165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>344600921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EokvhLyALCW4J_oid-MChKsuWarVULQiJi3GSidZLEqd2Inb_PQ67aiVO-DKW5nlGo3cQwpSklGTy_S6lXIqEFUymjBCeEko4S_dP0OKh8RQtiBI8KajKztCLEHaE0Fxw8hydUZZTmZF8gX7egXej622P70bbTa0ZIeCrw-DGrWlNZyvc3W4u8HI_eAjBuh6bvsZrV5kW30ILJgB2Dd7A5N02asP2EGzs3cAw2hrCS_SsMW2AV6d6jr59Wn69vErWX1afLy_WSSWYZIkSqjBQUiMgUyWRqixpQyWBShQNywvK6poQBSw-IwUjiktDBJiiNCU0wM_Ru-Pcwbv7CcKoOxsqaFvTg5uCzjljnEoRwTf_gDs3-T7upqlSmYjRkAgVR6jyLgQPjR687Yw_aEr0fAK903PSek5azyfQf0-g91F9fZo_lR3Uj-Ip8wi8PQEmxBQbb_rKhkcuy1VWqJn7cOR-2xYO_72Avt4s51_0k6Nvwwj7B9_4X1rmPBf6-2als-ubYvXxB9OS_wGt_rDC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199452710</pqid></control><display><type>article</type><title>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Jørgensen, H. ; Kjær, A. ; Knigge, U. ; Møller, M. ; Warberg, J.</creator><creatorcontrib>Jørgensen, H. ; Kjær, A. ; Knigge, U. ; Møller, M. ; Warberg, J.</creatorcontrib><description>The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.</description><identifier>ISSN: 0953-8194</identifier><identifier>EISSN: 1365-2826</identifier><identifier>DOI: 10.1046/j.1365-2826.2003.01032.x</identifier><identifier>PMID: 12716407</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science, Ltd</publisher><subject>5-HT agonists ; 5-HT receptors ; Animals ; Biological and medical sciences ; Corticotropin-Releasing Hormone - metabolism ; Fluoxetine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation ; hypothalamus ; Male ; microdialysis ; mRNA ; mRNA expression ; oxytocin ; Oxytocin - biosynthesis ; Oxytocin - blood ; Oxytocin - secretion ; Paraventricular Hypothalamic Nucleus - drug effects ; Paraventricular Hypothalamic Nucleus - metabolism ; Paraventricular Hypothalamic Nucleus - secretion ; Rats ; Rats, Wistar ; Receptors, Serotonin - classification ; Receptors, Serotonin - drug effects ; Receptors, Serotonin - physiology ; RNA, Messenger ; serotonin ; Serotonin - physiology ; Serotonin Receptor Agonists - pharmacology ; Serotonin Uptake Inhibitors - pharmacology ; Supraoptic Nucleus - drug effects ; Supraoptic Nucleus - metabolism ; Supraoptic Nucleus - secretion ; vasopressin ; Vasopressins - biosynthesis ; Vasopressins - blood ; Vasopressins - secretion</subject><ispartof>Journal of neuroendocrinology, 2003-06, Vol.15 (6), p.564-571</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Jun 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</citedby><cites>FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2826.2003.01032.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2826.2003.01032.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14794897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12716407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jørgensen, H.</creatorcontrib><creatorcontrib>Kjær, A.</creatorcontrib><creatorcontrib>Knigge, U.</creatorcontrib><creatorcontrib>Møller, M.</creatorcontrib><creatorcontrib>Warberg, J.</creatorcontrib><title>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</title><title>Journal of neuroendocrinology</title><addtitle>J Neuroendocrinol</addtitle><description>The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.</description><subject>5-HT agonists</subject><subject>5-HT receptors</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Corticotropin-Releasing Hormone - metabolism</subject><subject>Fluoxetine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation</subject><subject>hypothalamus</subject><subject>Male</subject><subject>microdialysis</subject><subject>mRNA</subject><subject>mRNA expression</subject><subject>oxytocin</subject><subject>Oxytocin - biosynthesis</subject><subject>Oxytocin - blood</subject><subject>Oxytocin - secretion</subject><subject>Paraventricular Hypothalamic Nucleus - drug effects</subject><subject>Paraventricular Hypothalamic Nucleus - metabolism</subject><subject>Paraventricular Hypothalamic Nucleus - secretion</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Serotonin - classification</subject><subject>Receptors, Serotonin - drug effects</subject><subject>Receptors, Serotonin - physiology</subject><subject>RNA, Messenger</subject><subject>serotonin</subject><subject>Serotonin - physiology</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><subject>Supraoptic Nucleus - drug effects</subject><subject>Supraoptic Nucleus - metabolism</subject><subject>Supraoptic Nucleus - secretion</subject><subject>vasopressin</subject><subject>Vasopressins - biosynthesis</subject><subject>Vasopressins - blood</subject><subject>Vasopressins - secretion</subject><issn>0953-8194</issn><issn>1365-2826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EokvhLyALCW4J_oid-MChKsuWarVULQiJi3GSidZLEqd2Inb_PQ67aiVO-DKW5nlGo3cQwpSklGTy_S6lXIqEFUymjBCeEko4S_dP0OKh8RQtiBI8KajKztCLEHaE0Fxw8hydUZZTmZF8gX7egXej622P70bbTa0ZIeCrw-DGrWlNZyvc3W4u8HI_eAjBuh6bvsZrV5kW30ILJgB2Dd7A5N02asP2EGzs3cAw2hrCS_SsMW2AV6d6jr59Wn69vErWX1afLy_WSSWYZIkSqjBQUiMgUyWRqixpQyWBShQNywvK6poQBSw-IwUjiktDBJiiNCU0wM_Ru-Pcwbv7CcKoOxsqaFvTg5uCzjljnEoRwTf_gDs3-T7upqlSmYjRkAgVR6jyLgQPjR687Yw_aEr0fAK903PSek5azyfQf0-g91F9fZo_lR3Uj-Ip8wi8PQEmxBQbb_rKhkcuy1VWqJn7cOR-2xYO_72Avt4s51_0k6Nvwwj7B9_4X1rmPBf6-2als-ubYvXxB9OS_wGt_rDC</recordid><startdate>200306</startdate><enddate>200306</enddate><creator>Jørgensen, H.</creator><creator>Kjær, A.</creator><creator>Knigge, U.</creator><creator>Møller, M.</creator><creator>Warberg, J.</creator><general>Blackwell Science, Ltd</general><general>Blackwell Science</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200306</creationdate><title>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</title><author>Jørgensen, H. ; Kjær, A. ; Knigge, U. ; Møller, M. ; Warberg, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>5-HT agonists</topic><topic>5-HT receptors</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Corticotropin-Releasing Hormone - metabolism</topic><topic>Fluoxetine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation</topic><topic>hypothalamus</topic><topic>Male</topic><topic>microdialysis</topic><topic>mRNA</topic><topic>mRNA expression</topic><topic>oxytocin</topic><topic>Oxytocin - biosynthesis</topic><topic>Oxytocin - blood</topic><topic>Oxytocin - secretion</topic><topic>Paraventricular Hypothalamic Nucleus - drug effects</topic><topic>Paraventricular Hypothalamic Nucleus - metabolism</topic><topic>Paraventricular Hypothalamic Nucleus - secretion</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Serotonin - classification</topic><topic>Receptors, Serotonin - drug effects</topic><topic>Receptors, Serotonin - physiology</topic><topic>RNA, Messenger</topic><topic>serotonin</topic><topic>Serotonin - physiology</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><topic>Supraoptic Nucleus - drug effects</topic><topic>Supraoptic Nucleus - metabolism</topic><topic>Supraoptic Nucleus - secretion</topic><topic>vasopressin</topic><topic>Vasopressins - biosynthesis</topic><topic>Vasopressins - blood</topic><topic>Vasopressins - secretion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jørgensen, H.</creatorcontrib><creatorcontrib>Kjær, A.</creatorcontrib><creatorcontrib>Knigge, U.</creatorcontrib><creatorcontrib>Møller, M.</creatorcontrib><creatorcontrib>Warberg, J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jørgensen, H.</au><au>Kjær, A.</au><au>Knigge, U.</au><au>Møller, M.</au><au>Warberg, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</atitle><jtitle>Journal of neuroendocrinology</jtitle><addtitle>J Neuroendocrinol</addtitle><date>2003-06</date><risdate>2003</risdate><volume>15</volume><issue>6</issue><spage>564</spage><epage>571</epage><pages>564-571</pages><issn>0953-8194</issn><eissn>1365-2826</eissn><abstract>The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science, Ltd</pub><pmid>12716407</pmid><doi>10.1046/j.1365-2826.2003.01032.x</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8194 |
ispartof | Journal of neuroendocrinology, 2003-06, Vol.15 (6), p.564-571 |
issn | 0953-8194 1365-2826 |
language | eng |
recordid | cdi_proquest_miscellaneous_73223165 |
source | MEDLINE; Access via Wiley Online Library |
subjects | 5-HT agonists 5-HT receptors Animals Biological and medical sciences Corticotropin-Releasing Hormone - metabolism Fluoxetine - pharmacology Fundamental and applied biological sciences. Psychology Gene Expression Regulation hypothalamus Male microdialysis mRNA mRNA expression oxytocin Oxytocin - biosynthesis Oxytocin - blood Oxytocin - secretion Paraventricular Hypothalamic Nucleus - drug effects Paraventricular Hypothalamic Nucleus - metabolism Paraventricular Hypothalamic Nucleus - secretion Rats Rats, Wistar Receptors, Serotonin - classification Receptors, Serotonin - drug effects Receptors, Serotonin - physiology RNA, Messenger serotonin Serotonin - physiology Serotonin Receptor Agonists - pharmacology Serotonin Uptake Inhibitors - pharmacology Supraoptic Nucleus - drug effects Supraoptic Nucleus - metabolism Supraoptic Nucleus - secretion vasopressin Vasopressins - biosynthesis Vasopressins - blood Vasopressins - secretion |
title | Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T11%3A24%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serotonin%20Stimulates%20Hypothalamic%20mRNA%20Expression%20and%20Local%20Release%20of%20Neurohypophysial%20Peptides&rft.jtitle=Journal%20of%20neuroendocrinology&rft.au=J%C3%B8rgensen,%20H.&rft.date=2003-06&rft.volume=15&rft.issue=6&rft.spage=564&rft.epage=571&rft.pages=564-571&rft.issn=0953-8194&rft.eissn=1365-2826&rft_id=info:doi/10.1046/j.1365-2826.2003.01032.x&rft_dat=%3Cproquest_cross%3E344600921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199452710&rft_id=info:pmid/12716407&rfr_iscdi=true |